期刊文献+

Caveolin-1:一种前列腺癌的标志物 被引量:2

Caveolin-1:A novel biomarker for prostate cancer
下载PDF
导出
摘要 前列腺癌严重威胁男性健康,早期诊断缺乏特异性生物标志物。caveolin-1(Cav-1)是一种功能基因,也是胞膜窖的重要外壳结构蛋白,与分子运输,细胞粘附和信号转导等多种细胞功能密切相关,在前列腺癌的发生发展中发挥重要作用。Cav-1可作为生物活性分子在前列腺癌微环境中促进肿瘤增殖和肿瘤血管生成。此外,Cav-1在前列腺癌原发灶及转移灶中均过度表达,尤其是转移灶。目前,Cav-1可在外周血被检测到,其表达水平对提高前列腺癌的诊断有提示意义,与预后相关。本文就Cav-1的结构、生物学特性以及与前列腺癌的相关性进行综述。 For lack of the biomarker, early diagnosis of prostate cancer is often difficult. Caveolin-1 ( Cav-1 ) is an important oncogene and a major structural coat protein of caveolae, which is involved in multiple cellular functions including molecular transport, cell adhesion, and signal transduction, as well as in the development and progression of prostate cancer. Cav-1 is secreted as a biologi- cally active molecule that promotes cell survival and angiogenesis within the tumor microenvironment, and is overexpressed in the meta- static and primary sites of human prostate cancer. Secreted Cav-1 can be detected in the peripheral blood, and its expression level has an indicative value in the diagnosis and prognosis of prostate cancer. This review focuses on the structure and biological characteristics of Cav-1 and its correlation with prostate cancer.
出处 《中华男科学杂志》 CAS CSCD 2012年第7期635-638,共4页 National Journal of Andrology
关键词 CAVEOLIN-1 前列腺癌 生物标志物 caveolin-1 prostate cancer biomarker
  • 相关文献

参考文献27

  • 1朱刚,刘明,万奔.早期前列腺癌的诊断与治疗[J].中华男科学杂志,2005,11(9):693-696. 被引量:31
  • 2Rao AR, Motiwala HG, Karim OM. The discovery of prostatespecific antigen. BJU Int, 2008, 101(1) : 5-10.
  • 3Andriole GL, Crawford ED, Grubb RL III, et al. Mortality resuits from a randomized prostate-cancer screening trial. N Engl J Med, 2009, 360(13) : 1310-1319.
  • 4Schroder FH, Hugosson J, Roobol M J, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med, 2009, 360(13): 1320-1328.
  • 5Carver LA, Schnitzer JE, Anderson RG, et al. Role of caveolae and lipid rafts in cancer: Workshop summary and future needs. Cancer Res, 2003, 63(20): 6571-6574.
  • 6Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol, 2005,288(3): C494-C506.
  • 7Steiner I, Jung K, Miller K, et al. Expression of endothelial factors in prostate cancer: A possible role of caveolin-1 for tumour progression. Oncol Rep, 2012, 27 (2) : 389-395.
  • 8Wu HC, Chang CH, Tsou YA, et al. Significant association of caveolin-1 ( CAV1 ) genotypes with prostate cancer susceptibility in Taiwan. Anticancer Res, 2011, 31(2) : 745-749.
  • 9Ifere GO, Equan A, Gordon K, et al. Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a down-stream prostate cell growth-suppressor gene. Cancer Epidemiol, 2010, 34(4) : 461-471.
  • 10Langeberg WJ, Tahir SA, Feng Z, et al. Association of caveolin- 1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes. Prostate, 2010, 70 (9) : 1020-1035.

二级参考文献50

  • 1陈占国,陶志华,陈晓东,李澄棣,李湘斌,杨建荣,温秀姝,林晓梅,朱燕英.前列腺癌患者外周血DD3 mRNA的检测及临床意义[J].中华检验医学杂志,2005,28(5):489-491. 被引量:11
  • 2Jemal A, Siegel R,Ward E, et al. CA CancerJ Clin 2008; 58(2):71-96.
  • 3Makarov DV, Loeb S, Getzenberg RH, et al. Annu Rev Med 2009; 60:139-151.
  • 4Roehrborn CG, McConnell J, Bonilla J, et al. J Urol 2000; 163(1): 13-20.
  • 5Thompson IM, Pauler DK, Goodman PJ, et al. N Engl J Med 2004; 350(22): 2239-2246.
  • 6Schroder FH, Roobol-Bouts M, Vis AN, et al. Urology 2001; 57(1): 83-90.
  • 7Catalona WJ, Loeb S, Han M. Ann Intern Med 2006; 144(6): 441-443.
  • 8Stamey TA, Johnstone IM, McNeal JE, et al. J Urol 2002; 167(1): 103-111.
  • 9Walz J, Haese A, Scattoni V, et al. Cancer 2008; 113 (10): 2695-2703.
  • 10Murphy GP, Kenny GM, Ragde H, et al. Urology 1998; 51(5A Suppl): 89-97.

共引文献31

同被引文献4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部